NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported a 9-percent increase in second-quarter revenues, including a 28-percent jump in revenues generated by its Specialty Diagnostics segment.

For the period ended June 30, total revenues came in at $3.11 billion, up from $2.85 billion a year ago. Wall Street had a consensus estimate of $3.05 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.